PRODUCTS

Active Ingredient: Human Albumin
Presentation: Amp. bottle 50 ml at 20%.
Indications: UMAN ALBUMIN is indicated as albumin reinstatement in patients with severe albumin deficiency, such as in:

• Emergency treatment of hypovolemic shock.
• Burns.
• Hypoproteinemia with or without edema such as those caused by major surgery, sepsis or in intensive care patients.
• Adult respiratory distress syndrome (ARDS).
• Cardiopulmonary bypass.
• Acute liver failure with or without coma.
• Neonatal hemolytic disease.
• Protein-rich fluid sequestration in conditions such as acute peritonitis, pancreatitis, mediastinitis and cellulitis.
• Erythrocyte resuspension in transfusions.
• Acute nephrosis, such as that which may result from lack of response to cyclophosphamide or steroid administration.
• Renal dialysis.

Storage:Store the product at a temperature not exceeding 30°C.
GLN: 7798087803425

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Desmopressin 20 mcg/1 ml Injectable Solution via I.M., I.V. or S.C.
Presentation: 10 vials of 20 mcg/1 ml.
Indications:

• Mild and moderate hemophilia A.
• Preparation for surgery of hemophiliacs and patients affected by von Willebrand's disease.
• Preparation of uremic patients (affected by increased bleeding time) for invasive maneuvers.

Storage: between 2° and 8°C
GLN: 7798087803456

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Human Immunoglobulin Anti-D (Rh0)
Presentation: Amp. Bottle 300 mcg (1500 U.I.)
Indications:

• Prophylaxis of anti-D (Rho) immunization in Rh negative (Rho, D) and Du positive women. Sensitization occurs particularly after childbirth, but can also occur during pregnancy.
• Likewise, aminocentesis, external cephalic version, abdominal trauma, antepartum hemorrhage, ectopic pregnancy or chorionic villus sampling, as well as threatened abortion and miscarriage, constitute potentially sensitizing events.
• Prophylaxis of anti-D (Rho) immunization in Rho (D) negative individuals after incompatible transfusions of Rh positive (D) blood or red cell concentrates.

Storage: up to 25°C
GLN: 7798087803531

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Antithrombin III from human plasma.
Presentation: Amp. bottle 500 U.I./10 ml and 1000 U.I./ 20 ml.
Indications: AT III KEDRION is indicated:

In patients with congenital antithrombin deficiency:For prophylaxis of deep vein thrombosis and Thromboembolism in clinical risk situations (especially in cases of surgical interventions or during the time of delivery), in association with heparin, when indicated. For the prevention of the progression of deep vein thrombosis and thromboembolism in association with heparin, when indicated.

In patients with acquired antithrombin deficiency: disseminated intravascular coagulation (DIC) associated with: severe sepsis, polytrauma, burns, pregnancy.

Other: acute consumption coagulopathy.

Storage: between 2° and 8°C
GLN: 7798087803548 and 7798087803555

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Prothrombinic Complex Concentrate - Factors IX, II and X.
Presentation: Amp. 500 U.I./20 ml bottle.
Indications: Prophylaxis and treatment of hemorrhages in:

• Patients with congenital deficiency - single or multiple - of the following factors: IX (hemophilia B or "Christmas" disease), II (prothrombin deficiency) or X ("Stuart- Prower" factor deficiency).
• Patients with acquired single or multiple prothrombin complex factor deficiency.

Storage: Between 2° and 8°C
GLN: 7798087803425

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Streptokinase
Presentation: 1.500.000 U.I. Ampoule bottle.
Indications:

• Acute myocardial infarction (in evolution).
• Pulmonary embolism
• Arterial thromboembolism (e.g. acute occlusions of peripheral arteries, chronic obstructive arterial disease, new thrombus formation after vascular interventions, obliterations of arterio-venous shunts, etc.).
• Venous thromboses (e.g. venous thromboses of organ vessels, acute deep venous thrombosis of the extremities and pelvis, new thrombus formation after vascular interventions).
• Occlusions of retinal vessels (arterial or venous thrombosis).

Storage: up to 25°C
GLN: 7798087800301

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Normal Human Immunoglobulin 50 g/l (at 5%).
Presentation: Injectable I.V. sol. 2,5; 5 and 10 g.
Indications: Substitutive therapy. Primary immunodeficiency syndromes:

• Agamaglobulinemia and congenital hypogamaglobulinemia.
• Common variable immunodeficiency.
• Severe combined immunodeficiency.
• Wiskott Aldrich syndrome.
• Myeloma or chronic lymphocytic leukemia with severe secondary hypogammaglobulinemia and recurrent infections.
• Children with congenital AIDS and recurrent infections.

Immunomodulatory effects. Idiopathic thrombocytopenic purpura (ITP), in children at high risk of bleeding or before surgical interventions to correct platelet counts.

• Guílláin Barré syndrome.
• Multifocal motor neuropathy.
• Kawasaki disease.
• Myasthenia gravis.

Storage: between 2° and 8°C.
GLN: 7798087803524, 7798087803500 and 7798087803517

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Human Plasma Coagulation Factor VIII.
Presentation: 500 U.I./10 ml and 1000 U.I./10 ml.
Indications: EMOCLOT is used in the following cases:

• in the treatment and prevention of bleeding in patients with hereditary deficiency of factor VIII activity (Hemophilia A);
• in the treatment of bleeding in patients with factor VIII activity deficiency secondary to other diseases;
• in the treatment of hemophiliac patients who have developed antibodies against factor VIII (inhibitors).

Storage: Between 2° and 8°C
GLN: 7798087803401 and 7798087803418

---

Links: Manufacturer
Other links:
Argentine Society of Hematology
Argentine Society of Intensive Care

---

Active ingredient: Human plasma coagulation factor IX.
Presentation: powder and solvent for solution for infusion of 500 IU/10ml and 1,000IU/10ml.
Indications: Prophylaxis and treatment of bleeding in patients with hemophilia B (congenital Factor IX deficiency and acquired Factor IX deficiency.
Treatment: Hemorrhages should be treated as early as possible. Treatment consists of slow intravenous administration of the concentrate containing the deficient plasma factor (FVIII or FIX).
Storage: no highter than 2° and 8°C. Protect from light.
GLN: GLN: 7798087800004

---

Links: Manufacturer
Other links:
Hemophilia Foundation
Argentine Society of Hematology

---

Active ingredient: Diclofenac Sodium, Betamethasone, Hydroxocobalamin.
Presentation: injectable solution x 3 and 6 ampoules of 3 ml each.
Indications: Analgesic, anti-inflammatory and antineuritic.

Treatment of intense inflammatory and painful processes with neuritic component-Articular and extra-articular rheumatic conditions, fibrolysis, myalgias, acute crises of lumbosciatica, cervicobrachialgias, neuralgias or severe radiculalgias (when they do not respond to monotherapy).
Storage: Store at room temperature (no higher than 30 degrees C). Protect from light.
GLN: 7798087800004

---

Links: -
Other links:
Argentine Association for the Study of Pain

---

Active ingredient: Salbutamol HFA
Presentation: 10ml - 200 doses
Indications: Antiasthmatic of instantaneous action. Bronchodilator.

• Immediate relief of symptoms in an asthma attack.
• Stops the asthma attack in progress.
• Bronchodilator in bronchial asthma and chronic bronchitis with or without pulmonary emphysema.
• Prophylactic treatment of bronchial spasm in exertional asthma.

Storage: -
GLN: 7798087800004

---

Links: Fabricante
Other links:
Argentine Association of Allergy, Asthma and Immunology

---

Presentation: pediatric - adult
Indications: Anti-static valved spacer chamber

• Latex free
• Anti-static
• MaxAir® is a valved spacer chamber designed to optimize medication delivery when using metered dose inhalers (MDI).

COMPRAR ADULTO COMPRAR NIÑO

Precauciones:

• Use only under the direction of a medical professional and read instructions before use.
• Do not leave AIRMAX® within reach of children without adult care.
• Do not disassemble the product beyond the washing instructions, or the product may be damaged.
• AIRMAX® is a medical product. To ensure proper performance, it must be sanitized according to these instructions. It should not be washed in a dishwasher.
• be washed in the dishwasher.
• The product may be permanently damaged if boiled, sterilized or washed at temperatures above 70°C.
• Read and follow the instructions provided with your MDI.
• This product does not contain latex.

GLN: 7798087800004

---

Links:
Argentine Association of Allergy, Asthma and Immunology

---

Active ingredient: Budesonide
Presentation: Pediatric; 10 ml metered-dose aerosol (200 doses of 50 mcg budesonide/dose), with mouthpiece adapter and DOSE INDICATOR. - Adult; 10 ml metered-dose aerosol (200 doses of 200 mcg budesonide/dose), with mouthpiece adapter and DOSE INDICATOR incorporated into the adapter.

---

Links:
Manufacturer Argentine Association of Allergy, Asthma, and Immunology

---

Active ingredient: Desmopressin 20 mcg/1 ml Injectable Solution via I.M., I.V. or S.C.
Presentation: 3 vials of 20 mcg/1 ml
Indications:

• Mild and moderate hemophilia A.
• Preparation for surgery in hemophilic and von Willebrand disease affected patients.
• Preparation of uremic patients (affected by increased bleeding time) for invasive procedures.

Storage: 2° and 8°C
GLN: 7798087803456

---

Links:
Manufacturer Manufacturer Argentine Society of Hematology Argentine Society of Intensive Care Therapy

---

TRO-DONEX 2 CPDA-1-450 Safety
Presentation: 1 Aluminum Pouch x 5 units. Each packaged in a sealed transparent foil contains 1 bag with 63 ml of CPDA-1 anticoagulant solution USP for the collection of 450 ml of blood + an empty transfer bag.
TRO-DONEX-3 CPDA-1 Safety
Presentation: 1 Aluminum Pouch x 4 units. Each packaged in a sealed transparent foil contains 1 bag with 63 ml of CPDA-1 anticoagulant solution USP for the collection of 450 ml of blood + two empty transfer bags.
TRO-DONEX 3 CPD/SAGM-450 Safety TOTM
Presentation: 1 Aluminum Pouch x 4 units. Each packaged in a sealed transparent foil contains 1 bag with 63 ml of anticoagulant CPD solution USP for the collection of 450 ml of blood + a transfer bag with 100 ml of SAGM + an empty bag.
TRO-DONEX-4 CPDA-1 Safety
Presentation: 1 Aluminum Pouch x 3 units. Each packaged in a sealed transparent foil contains 1 bag with 63 ml of CPDA-1 anticoagulant solution USP for the collection of 450 ml of blood + three empty transfer bags.
TRO-DONEX 4 CPD/SAGM-450 Safety TOTM
Presentation: 1 Aluminum Pouch x 3 units. Each packaged in a sealed transparent foil contains 1 bag with 63 ml of anticoagulant CPD solution USP for the collection of 450 ml of blood + one transfer bag with 100 ml of SAGM + two empty transfer bags.

---